Catalyst Pharmaceuticals CPRX
CPRX
$31.49 +0.00 (+0.00%)
At close: Jul 21, 2026 · 4:00 PM EDT

Catalyst Pharmaceuticals (CPRX) Cash from Operations (2010 - 2026)

Updated

Catalyst Pharmaceuticals' Cash from Operations was $59.59 million in Q1 2026, down 0.8% from $60.04 million a year earlier but up 32.7% from the prior quarter.

Analysis

Catalyst Pharmaceuticals (CPRX) Cash from Operations (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Catalyst Pharmaceuticals' Cash from Operations was $208.21 million through Mar 31, 2026, down 22.3% year-over-year; for FY2025, it came in at $208.67 million, down 13.0% from FY2024.

  • Cash from Operations shows a five-year compound annual growth rate of 35.9% (FY2020 to FY2025).
  • In earlier years, Cash from Operations was $239.81 million in FY2024 (+67.0%), $143.6 million in FY2023 (+23.7%), $116.05 million in FY2022 (+92.2%) and $60.37 million in FY2021 (+34.1%).
  • Quarterly Cash from Operations has moved between $8.48 million (Q1 2022) and $72.87 million (Q3 2024) over five years.
  • Compared with a year earlier, Cash from Operations has declined for three straight quarters, with growth averaging 25.5% over the last eight quarters.
  • The best year-over-year quarter for Cash from Operations over five years was Q1 2024 (growth of 164.5%); the worst was Q3 2025 (a decline of 55.5%).
  • Per Business Quant data, CPRX's Cash from Operations in the three quarters before Q1 2026 was $44.89 million (Q4 2025), $32.44 million (Q3 2025) and $71.3 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 8.62 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 3.44 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 5.88 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 4.58 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 4.00 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 3.57 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 835.00 Mn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 1.13 Bn
10 Catalyst Pharmaceuticals 3.85 Bn 1.04 Bn 134.92 Mn 59.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 59.59 Mn
Dec 31, 2025 44.89 Mn
Sep 30, 2025 32.44 Mn
Jun 30, 2025 71.30 Mn
Mar 31, 2025 60.04 Mn
Dec 31, 2024 70.88 Mn
Sep 30, 2024 72.87 Mn
Jun 30, 2024 64.14 Mn
Mar 31, 2024 31.93 Mn
Dec 31, 2023 55.65 Mn
Sep 30, 2023 45.13 Mn
Jun 30, 2023 30.75 Mn
Mar 31, 2023 12.07 Mn
Dec 31, 2022 40.08 Mn
Sep 30, 2022 41.30 Mn
Jun 30, 2022 26.19 Mn
Mar 31, 2022 8.48 Mn
Dec 31, 2021 19.18 Mn
Sep 30, 2021 21.71 Mn
Jun 30, 2021 15.68 Mn
API Access

Catalyst Pharmaceuticals Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=CPRX&period=max&api_key=YOUR_API_KEY